Navigation Links
Lupin Gets USFDA Approval For Quinapril Tablets

Pharmaceutical company Lupin Ltd today said it has recieved the final approval from USFDA to market its Abbreviated New Drug Application (ANDA) of hypertension medicine Quinapril in US. //

The company informed the Bombay Stock Exchange that the approval is for the multiple dosages of strengths 5 mg, 10 mg, 20 mg and 40 mg.

Quinapril is a AB-rated generic equivalent of Pfizer's hypertension drug Accupril and its market is estimated to be about 300 million dollars in the US till December 2005.

This is the company's 13th ANDA aprroval by USFDA till date and third in the current fiscal.

(Source:PTI News)

Page: 1

Related medicine news :

1. Lupin flour may cause peanut allergy like reactions
2. US Court Rules Against Lupin in Ramipril Patent Case
3. Lupin Gets USFDA Approval for Meloxicam
4. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
5. Lupin Gets Tentative Nod from FDA for Antidepressant Drug
6. Morepan to file new drug applications with the USFDA
7. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
8. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
9. Ranbaxy Gets USFDA Nod For Simvastatin
10. Aurobindo Receives Approval from USFDA for anti-AIDS drug
11. Aurobindo Gets Tentative USFDA Approval For Its HIV-1 Drug
Post Your Comments:

(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology: